DB-OTO Results in the New England Journal of Medicine Showcase Dramatic and Sustained Improvements in Hearing and Speech Perception in Children with Profound Genetic Hearing Loss – Regeneron

1. DB-OTO Results in the New England Journal of Medicine Showcase Dramatic and Sustained Improvements in Hearing and Speech Perception in Children with Profound Genetic Hearing Loss  Regeneron
2. Regeneron, with ‘game-changing’ new data, to seek approval of hearing loss gene therapy  BioPharma Dive
3. Regeneron amplifies CHORD progression, sharing updated data on hearing loss gene therapy  Fierce Biotech

Continue Reading